Four democratic senators, Richard Blumenthal (D-CT), Kamala Harris (D-CA), Amy Klobuchar (D-MN) and Jeff Merkley (D-OR), have introduced a bill aimed at blocking drug price hikes....
Bagsværd, Denmark, 3 December 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European...
Bagsværd, Denmark, 5 November 2018 - As part of the up to DKK 15 billion 2018 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an...
Shares of clinical-stage biopharmaceutical company Zafgen, Inc. (NASDAQ:ZFGN) slumped 40.5% after the company announced that the FDA has placed a clinical hold on the...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Buy||BUY||Strong Buy||Strong Buy||Strong Sell|
|Summary||Strong Buy||Buy||Strong Buy||Strong Buy||Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Inside Up||15||Current|
|Three Inside Up||1H||Current|
|Doji Star Bearish||5H||4||Dec 12, 2018 12:00PM|
|Gravestone Doji||5H||4||Dec 12, 2018 12:00PM|
|Three Outside Up||1H||5||Dec 14, 2018 10:00AM|
|Wheaton Precious Metals||18.94||19.65||18.32||+2.35||+14.17%||14.95M||14/12|
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$2000||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.